Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • schoir schoir Jan 25, 2012 2:58 PM Flag

    Clinical Trials

    Results from this follow on study are due in March. Positive results could further spur an upword climb. http://clinicaltrials.gov/ct2/show/NCT01403155?term=inovio&rank=6

    PHASE I, OPEN-LABEL, SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF AN H5 INFLUENZA PLASMID VACCINE (INO-3401) IN HEALTHY ADULTS PREVIOUSLY VACCINATED WITH VGX-3400X

    Another possible source of new is Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity in Healthy Adult Males of a DNA Plasmid Vaccine for HS Avian Influenza (VGX-3400) Administered by Intramuscular (IM) Injection Followed by Electroporation (EP)with a completion date is February 2012.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INO
7.25-0.04(-0.55%)Aug 3 4:00 PMEDT